Last reviewed · How we verify

NCT06370312

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints

Recruiting now Last updated 25 June 2025
What this trial tests

trial testing Trapeziectomy in Osteoarthritis Thumb in 120 participants. Currently enrolling.

Timeline
1 May 2024
Primary endpoint
30 April 2026
30 April 2027

Quick facts

Lead sponsorRegion Skane
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date1 May 2024
Primary completion30 April 2026
Estimated completion30 April 2027
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

25 and older, any sex, with Osteoarthritis Thumb or Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study project aims at examining molecular markers in synovial fluid, bone and articular cartilage from osteoarthritic thumb basal joints. The degradation of extracellular matrix (ECM) proteins in thumb basal joints will be evaluated in association to the metabolic profile of the patient, but we also aim to compare the ECM degradation and inflammatory profiles with articular cartilage degradation ECM profile from knee joints with osteoarthritis. A third aim is to evaluate associations between patient-reported hand function, pain, strength and range of thumb motion to analyses of synovial fluid.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Trapeziectomy

Trials testing the same drug.

Other recruiting trials for Osteoarthritis Thumb

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06370312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing